The Cycle for Survival event is gearing up for its 2026 season, marking a significant milestone as it celebrates 20 years dedicated to funding rare cancer research. Organized by Memorial Sloan Kettering Cancer Center, this initiative has transformed into a nationwide movement, uniting participants across the country in a shared mission to combat rare cancers. With over 75% of the bikes already reserved for the upcoming season, the enthusiasm and commitment of the community are palpable.

A Legacy of Hope and Community Support

Cycle for Survival was founded in 2007 by Jennifer Goodman Linn, an MSK patient, and her husband, Dave Linn. What began as a local event has evolved into a powerful force in cancer research, raising more than $415 million to date. The funds generated from these stationary cycling events directly support innovative clinical trials and major scientific initiatives at MSK, focusing on rare cancers that often receive limited attention and funding. Participants can join the event without any prior cycling experience, making it an inclusive opportunity for anyone wishing to contribute to cancer research. The 2026 season will feature events in 16 cities, including a new location in Philadelphia, and will see participation from countless individuals who come together to ride, share stories, and honor loved ones affected by cancer.

New Partnerships and Expanding Reach

This year's event will introduce NOBULL as the Official Performance Apparel Sponsor, a collaboration that aligns with the values of community and wellness that Cycle for Survival embodies. NOBULL’s owner, Mike Repole, has a personal connection to the cause, further reinforcing the importance of partnership in driving progress against cancer. As part of the event, participants will have the chance to earn exclusive Cycle for Survival x NOBULL gear through their fundraising efforts, adding an additional incentive to engage and contribute. This partnership not only enhances the experience for participants but also elevates the visibility of the cause, potentially attracting new supporters and participants.

The Importance of Funding Rare Cancer Research

Rare cancers, which include various blood, brain, ovarian, pancreatic, and pediatric cancers, affect nearly half of all cancer patients. However, these cancers often lack adequate research funding, leaving patients with limited treatment options. Cycle for Survival aims to bridge this gap by providing crucial financial support for groundbreaking research at MSK. Dr. Ross Levine, MSK’s Chief Scientific Officer, highlights the transformative impact of Cycle for Survival on rare cancer research. He notes that, historically, there were few treatment options available for rare cancers due to a lack of dedicated research. Thanks to the funding generated by Cycle for Survival, significant advancements have been made, resulting in the development of new therapies and improved patient outcomes.

The Role of AI in Advancing Cancer Research

As we look to the future of cancer treatment innovation, the integration of artificial intelligence (AI) into oncology research is becoming increasingly relevant. AI has the potential to revolutionize how researchers analyze data, identify new therapeutic targets, and develop personalized treatment plans for patients. For instance, AI algorithms can assist in genomic profiling, helping to detect mutations that may inform treatment decisions for rare cancers. The collaboration between fundraising initiatives like Cycle for Survival and advancements in AI cancer research represents a powerful synergy that could lead to more effective therapies and improved patient outcomes. As researchers continue to explore the capabilities of AI in oncology, the funding raised through events like Cycle for Survival will be instrumental in supporting these pioneering efforts.

Conclusion: A Call to Action

The Cycle for Survival event exemplifies the power of community in the fight against cancer, particularly rare cancers that often go underfunded. With its rich history and commitment to innovation, this initiative not only provides hope for patients and their families but also fosters a vibrant community that rallies together for a common cause. As we enter the 2026 season, the importance of participating, donating, and supporting rare cancer research has never been clearer. For those interested in staying informed about the intersection of AI and cancer research, as well as the ongoing efforts to combat rare cancers, resources like CureCancerWithAi.com offer valuable insights and updates. Together, we can contribute to a future where cancer is no longer an insurmountable challenge but a condition that is effectively treated and managed.

Readers who want more plain-language context on AI and oncology can also explore the Cure Cancer With AI blog and learn more about the project.